Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile Infection

Digestive Diseases and Sciences

Volumn 60, Issue 1, 2015, Pages 181-185

  Zainah, Hadeel ^a   Hassan, Mona ^a   Shiekh Sroujieh, Laila ^a   Hassan, Syed ^b   Alangaden, George ^a   Ramesh, Mayur ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clostridium difficile; Colitis; Fecal transplant; Recurrent infection

Indexed keywords

AGED; BIOLOGICAL THERAPY; COLONOSCOPY; DIGESTIVE TRACT INTUBATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMAN; INTESTINE; MALE; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RECURRENT DISEASE; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; COLONOSCOPY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; INTESTINES; INTUBATION, GASTROINTESTINAL; MALE; MICROBIOTA; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84928009180     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3296-y     Document Type: Article

References (23)

1. Tabak YP, Zilberberg MD, Johannes RS, et al. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013;34:588–596.
2. Van Nood E, Vreize E, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med. 2013;368:407–415.
3. Gough E. Systematic review of intestinal microbiota transplantation (Fecal Bacteriotherapy) for recurrent clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.
4. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by administration of donor flora. J Clingastroenterol. 2010;44:551–561.
5. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–859.
6. Zar FA. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–307.
7. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012;55:S154–S161.
8. Crawford T, Huesqen E, Danziqer L. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection. Am J Health Syst Pharm. 2012;69:933–943.
9. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044–1049.
10. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65.
11. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.
12. Reeves AE, Theriot CM, Bergin IL, et al. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes. 2011;2:145–158.
13. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile- associated diarrhea. J Infect Dis. 2008;197:435–438.
14. You DM, Franzos MA, Holman RP. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med. 2008;148:632–633.
15. Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, et al. Successful colonoscopic fecal transplant for severe acute Clostridium difficile. Rev Gastroenterol Mex. 2012;77:40–42.
16. Trubiano, JA, Gardiner B Kwong JC et al. Fecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit. Eur J Gastroenterol Hepatol. 2013;25:255–257.
17. Weingarden AR, Hamilton MJ, Sadowsky MJ, et al. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol. 2013; (Epub ahead of print).
18. Neemann K, Eichele DD, Smith PW, et al. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012;14:E161–E165.
19. Zainah H, Silverman A. Fecal bacteriotherapy: a case report in an immunosuppressed patient with ulcerative colitis and recurrent Clostridium difficile infection. Case Rep Infect Dis. 2012;2012:810943.
20. Jarchum I, Liu M, Lipuma L et al. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun. 79:1498–1503.
21. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile Infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–455.
22. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2007;28:140–145.
23. Brandt LJ, Borody TJ, Campbell J. Endoscopic fecal microbiota transplantation: “first-line” treatment for severe Clostridium difficile infection? J Clin Gastroenterol. 2011;45:655–657.